Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety, Immunogenicity”

5,603 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,603 results

Testing effectiveness (Phase 2)Temporarily pausedNCT05150496
What this trial is testing

Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVac®) Vaccine in Healthy Adults in Turkey

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 640
Large-scale testing (Phase 3)Study completedNCT03546842
What this trial is testing

Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017)

Who this might be right for
Papillomavirus InfectionsUterine Cervical NeoplasmsVulvar Neoplasms+3 more
Merck Sharp & Dohme LLC 201
Early research (Phase 1)Study completedNCT00001020
What this trial is testing

A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 28
Early research (Phase 1)Study completedNCT00902824
What this trial is testing

Safety and Immunogenicity of TBC-M4, a MVA HIV Vaccine Alone or in a Prime-Boost Regimen With ADVAX DNA HIV Vaccine

Who this might be right for
HIV Infections
International AIDS Vaccine Initiative 32
Large-scale testing (Phase 3)Study completedNCT04204096
What this trial is testing

Immune Equivalence Between Multi-dose and Single Dose Formulation of Vi-DT and Their Overall Safety (Phase III)

Who this might be right for
Typhoid
International Vaccine Institute 1,800
Large-scale testing (Phase 3)Study completedNCT03574389
What this trial is testing

A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Infants and Young Children

Who this might be right for
Pneumococcal InfectionsPneumococcal Conjugate Vaccine
Pfizer 936
Testing effectiveness (Phase 2)Study completedNCT00715910
What this trial is testing

The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Adolescents/Adults

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 818
Early research (Phase 1)Active Not RecruitingNCT06436742
What this trial is testing

A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)

Who this might be right for
Congenital Myasthenic SyndromeCMS
argenx 15
Early research (Phase 1)Study completedNCT05092386
What this trial is testing

Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

Who this might be right for
Pneumococcal Infections
Sinovac Life Sciences Co., Ltd. 310
Early research (Phase 1)Study completedNCT03673020
What this trial is testing

Phase 1a Study to Evaluate Immunogenicity of ASV®

Who this might be right for
Solid Tumor, Adult
Agenus Inc. 3
Post-approval studies (Phase 4)Study completedNCT01138215
What this trial is testing

The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children

Who this might be right for
HIV InfectionsVaricella-zoster Virus
The HIV Netherlands Australia Thailand Research Collaboration 60
Early research (Phase 1)Looking for participantsNCT07676890
What this trial is testing

A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVIV Vaccine in Patients With Ovarian Cancer After Surgery

Who this might be right for
Ovarian CancermRNA Vaccine
West China Hospital 9
Large-scale testing (Phase 3)Active Not RecruitingNCT05759520
What this trial is testing

Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants

Who this might be right for
Streptococcus Pneumoniae Infection
Fosun Adgenvax Biopharmaceutical Co.,Ltd. 1,800
Testing effectiveness (Phase 2)Ended earlyNCT00333424
What this trial is testing

Thai Prophylactic HIV Vaccine Phase I Study

Who this might be right for
HIV
Kirby Institute 8
Early research (Phase 1)Looking for participantsNCT07305818
What this trial is testing

NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease

Who this might be right for
Graves Disease
Merida Biosciences 100
Early research (Phase 1)Study completedNCT02780388
What this trial is testing

A Phase 1b Study of MEDI4920 in Participants With Adult-onset Rheumatoid Arthritis

Who this might be right for
Adult Onset Rheumatoid Arthritis
Amgen 57
Large-scale testing (Phase 3)UnknownNCT05911061
What this trial is testing

A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination

Who this might be right for
COVID-19
WestVac Biopharma Co., Ltd. 4,950
Early research (Phase 1)UnknownNCT04864379
What this trial is testing

Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Sir Run Run Shaw Hospital 30
Early research (Phase 1)Study completedNCT03463369
What this trial is testing

A First-In-Human Study to Evaluate Safety, Tolerability, Reactogenicity, and Immunogenicity of JNJ-64300535, a DNA Vaccine, Administered by Electroporation-Mediated Intramuscular Injection, in Participants With Chronic Hepatitis B Who Are on Stable Nucleos(t)Ide Therapy and Virologically Suppressed

Who this might be right for
Hepatitis B, Chronic
Janssen Sciences Ireland UC 30
Early research (Phase 1)Study completedNCT03382405
What this trial is testing

Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus Vaccines mRNA-1647 and mRNA-1443 in Healthy Adults

Who this might be right for
Cytomegalovirus Infection
ModernaTX, Inc. 181
Next Page